168 related articles for article (PubMed ID: 15608443)
1. Efficacy of docetaxel as a second-line chemotherapy for thymic carcinoma.
Oguri T; Achiwa H; Kato D; Maeda H; Niimi T; Sato S; Ueda R
Chemotherapy; 2004 Dec; 50(6):279-82. PubMed ID: 15608443
[TBL] [Abstract][Full Text] [Related]
2. [A case of thymic carcinoma responding to combination chemotherapy with nedaplatin, etoposide, and ifosfamide].
Kato D; Achiwa H; Sato S; Bessho Y; Shimizu S; Hattori N; Maeda H; Niimi T; Oguri T; Ueda R
Gan To Kagaku Ryoho; 2005 Mar; 32(3):377-9. PubMed ID: 15791821
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel for platinum-refractory advanced thymic carcinoma.
Watanabe N; Umemura S; Niho S; Kirita K; Matsumoto S; Yoh K; Ohmatsu H; Goto K
Jpn J Clin Oncol; 2015 Jul; 45(7):665-9. PubMed ID: 25840444
[TBL] [Abstract][Full Text] [Related]
4. [A case of relapsed thymic carcinoma that responded remarkably to chemotherapy with CPT-11].
Takamizawa A; Koizumi T; Kubo K; Sekiguchi M; Honda T
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2115-8. PubMed ID: 9838915
[TBL] [Abstract][Full Text] [Related]
5. A Case of Thymic Carcinoma with Bone and Cerebral Metastases Treated with Stereotactic Radiosurgery and Chemotherapy.
Kropf J; Castaneira G; Luc LT; Oriala C; Field Z; Rico A; Carlan SJ
Am J Case Rep; 2019 Nov; 20():1669-1674. PubMed ID: 31719514
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy with carboplatin and paclitaxel after failure of primary chemotherapy for advanced thymic carcinoma. A report of three cases and review of the literature.
Watanabe K; Shinkai M; Goto H; Yoshikawa S; Yamaguchi N; Hara Y; Shinoda M; Moriyama Y; Rubin BK; Ishigatsubo Y; Kaneko T
Tumori; 2013; 99(4):e172-6. PubMed ID: 24326856
[TBL] [Abstract][Full Text] [Related]
7. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
8. Amrubicin as second-line and beyond treatment for platinum-refractory advanced thymic carcinoma.
Hirai F; Seto T; Yamanaka T; Toyozawa R; Inamasu E; Kojo M; Toyokawa G; Morodomi Y; Shiraishi Y; Takenaka T; Yamaguchi M; Takenoyama M; Ichinose Y
Jpn J Clin Oncol; 2013 Oct; 43(10):1018-22. PubMed ID: 23917962
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of Docetaxel plus Cisplatin Chemotherapy for Myasthenia Gravis Patients with Metastatic Thymoma.
Qi G; Liu P; Dong H; Gu S; Yang H; Xue Y
Tohoku J Exp Med; 2017 Apr; 241(4):281-286. PubMed ID: 28381664
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
Fukuda M; Obase Y; Miyashita N; Kobashi Y; Mohri K; Ueno S; Hayama M; Shimizu K; Nishimura H; Nakata M; Oka M
Anticancer Res; 2007; 27(3B):1601-4. PubMed ID: 17595782
[TBL] [Abstract][Full Text] [Related]
11. Second-line combination chemotherapy with docetaxel and nedaplatin for Cisplatin-pretreated refractory metastatic/recurrent esophageal squamous cell carcinoma.
Jin J; Xu X; Wang F; Yan G; Liu J; Lu W; Li X; Tucker SJ; Zhong B; Cao Z; Wang D
J Thorac Oncol; 2009 Aug; 4(8):1017-21. PubMed ID: 19542899
[TBL] [Abstract][Full Text] [Related]
12. Aggressive multimodality treatment of invasive thymic carcinoma.
Greene MA; Malias MA
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):434-6. PubMed ID: 12579125
[No Abstract] [Full Text] [Related]
13. Thymic carcinoma. A distinct clinical entity responsive to chemotherapy.
Weide LG; Ulbright TM; Loehrer PJ; Williams SD
Cancer; 1993 Feb; 71(4):1219-23. PubMed ID: 8435796
[TBL] [Abstract][Full Text] [Related]
14. [Six cases of thymic carcinoma: a clinical review].
Takemura Y; Yuba T; Kono K; Hosogi K; Osugi S; Kuwahara H; Nagata K; Harada H; Yokomura I; Iwasaki Y
Nihon Kokyuki Gakkai Zasshi; 2004 Jul; 42(7):660-4. PubMed ID: 15357270
[TBL] [Abstract][Full Text] [Related]
15. [A case of postoperative thymic carcinoma recurrence that was effectively treated with combination chemotherapy of nedaplatin and docetaxel].
Kataoka Y; Okamoto K; Kitamura T; Hayama M; Tanaka H; Kanai O; Kobayashi T; Okamura M; Inoue H; Oshio M; Motoishi M; Mio T; Sawai S; Hanaoka J
Gan To Kagaku Ryoho; 2013 Dec; 40(13):2561-3. PubMed ID: 24335370
[TBL] [Abstract][Full Text] [Related]
16. Thymic carcinoma in children.
Yaris N; Nas Y; Cobanoglu U; Yavuz MN
Pediatr Blood Cancer; 2006 Aug; 47(2):224-7. PubMed ID: 16007580
[TBL] [Abstract][Full Text] [Related]
17. [The usefulness of induction chemotherapy in cases with tumors showing border-line pathological aspects between thymoma and thymic carcinoma].
Nonami Y; Moriki T; Yamamoto A; Yamashiro T; Sasaguri S; Nakata H; Kobayashi M
Kyobu Geka; 2002 Oct; 55(11):953-8. PubMed ID: 12391692
[TBL] [Abstract][Full Text] [Related]
18. [Thymic cancer effectively treated by combination chemotherapy of carboplatin and etoposide with concurrent radiotherapy].
Kaira K; Watanabe R; Takise A; Endou K; Kamiyoshihara M; Mori M
Gan To Kagaku Ryoho; 2005 Nov; 32(12):1989-92. PubMed ID: 16282742
[TBL] [Abstract][Full Text] [Related]
19. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of combined docetaxel and nedaplatin chemotherapy for recurrent esophageal cancer compared with conventional chemotherapy using cisplatin and 5-fluorouracil: a retrospective study.
Fujita Y; Hiramatsu M; Kawai M; Sumiyoshi K; Nishimura H; Tanigawa N
Dis Esophagus; 2008; 21(6):496-501. PubMed ID: 18840134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
